French ultrasound vendor returns to U.S. market
Kontron Medical has reentered the North American marketplace. The company, which is owned by the French firm Amphora, hopes to win customers in the U.S. with its Sigma 330, a midrange color-flow ultrasound system.The product will be featured at the
Kontron Medical has reentered the North American marketplace. The company, which is owned by the French firm Amphora, hopes to win customers in the U.S. with its Sigma 330, a midrange color-flow ultrasound system.
The product will be featured at the upcoming annual meeting of the American College of Obstetricians and Gynecologists April 28 to May 2. It will be sold through a network of eight dealers in the U.S. and two in Canada. Primary customers will be specialists in ob/gyn, as well as other office-based physicians who might use the system for vascular or general-purpose scanning.
“In the next year we hope to see where we fit in the market and make sure our product is answering market needs,” said Dan Meibers, product and marketing manager for Kontron Medical.
It has been several years since Kontron equipment has been sold in the U.S. The company left the U.S. because of a mismatch between its product line and the marketplace. Kontron had offered only lower end systems, whereas the U.S. market has typically preferred high-performance systems. Sigma 330 offers Kontron the chance to get back where it needs to be, according to Meibers.
“To be a player, you need to sell in the largest market in the world,” he said.
Sigma 330 represents a change for the company. The color-flow system delivers the capability lacking in its previous offerings. The midrange system comes in three different configurations and can be equipped with several types of probes, including curved-array, linear-array, and convex transducers, as well as intracavity products with biopsy capabilities. Among the features are 3-D gray-scale, color-flow Doppler, and high-frequency imaging.
Also in the Kontron product line will be a low-end, black-and-white version called Sigma 110, but Meibers expects the higher performance system to be the more popular. The 3-D capability should help distinguish the system from competitors, he said.
“To be able to bring an affordable color-flow system with 3-D into the midrange market should be a valuable advantage for us,” he said.
Emerging AI Mammography Model May Enhance Clarity for Initial BI-RADS 3 and 4 Classifications
May 21st 2025In a study involving over 12,000 Asian women, researchers found that an artificial intelligence (AI) model converted over 83 percent of false positives in patients with initial BI-RADS 3 and 4 assessments into benign BI-RADS categories.
Study: Abbreviated Breast MRI Offers Equivalent Accuracy to mpMRI for Women with Dense Breasts
May 20th 2025Emerging research suggests that abbreviated breast MRI offers comparable sensitivity and specificity as multiparametric MRI in women with extremely dense breasts with a nearly 50 percent reduction in reading time for radiologists.
Can AI Predict Future Lung Cancer Risk from a Single CT Scan?
May 19th 2025In never-smokers, deep learning assessment of single baseline low-dose computed tomography (CT) scans demonstrated a 79 percent AUC for predicting lung cancer up to six years later, according to new research presented today at the American Thoracic Society (ATS) 2025 International Conference.
